Cargando…
The Heparan Sulfate Proteoglycan Syndecan-1 Triggers Breast Cancer Cell-Induced Coagulability by Induced Expression of Tissue Factor
Syndecan-1 (Sdc-1) upregulation is associated with poor prognosis in breast cancer. Sdc-1 knockdown results in reduced angiogenesis and the dysregulation of tissue factor (TF) pathway constituents. Here, we evaluate the regulatory mechanisms and functional consequences of the Sdc-1/TF-axis using Sdc...
Autores principales: | Hassan, Nourhan, Bückreiß, Nico, Efing, Janes, Schulz-Fincke, Marie, König, Philipp, Greve, Burkhard, Bendas, Gerd, Götte, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047229/ https://www.ncbi.nlm.nih.gov/pubmed/36980251 http://dx.doi.org/10.3390/cells12060910 |
Ejemplares similares
-
The Tissue Factor Pathway in Cancer: Overview and Role of Heparan Sulfate Proteoglycans
por: Hassan, Nourhan, et al.
Publicado: (2023) -
The Cell Surface Heparan Sulfate Proteoglycan Syndecan-3 Promotes Ovarian Cancer Pathogenesis
por: Hillemeyer, Lara, et al.
Publicado: (2022) -
The heparan sulfate proteoglycan Syndecan-1 influences local bone cell communication via the RANKL/OPG axis
por: Timmen, Melanie, et al.
Publicado: (2020) -
Mapping the Interactome of the Nuclear Heparan Sulfate Proteoglycan Syndecan-1 in Mesothelioma Cells
por: Kumar-Singh, Ashish, et al.
Publicado: (2020) -
Molecular cloning and characterization of N-syndecan, a novel transmembrane heparan sulfate proteoglycan
Publicado: (1992)